No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt